Population
Type 3 poliovirus particles (C antigen and D antigen) and monoclonal antibodies
Design
Preclinical
Authors
Loading...
May inform poliovirus particle-based vaccines; leaves open immunogenicity in humans.
The study demonstrates that the amino acid sequences involved in neutralizing infectious type 3 poliovirus are also present on non-infectious particles but in different configurations.
Ferguson et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: